AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2013
May 3, 2013
35134_dirs_2013-05-03_f199a3ed-0fec-41a5-b1a5-5b6139253bf3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2013-05-01
Reporting Person: Milligan John C.K. IV (Director, President/Secretary)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-05-01 | Non-qualified Stock Option | $2.64 | A | 50000 | Acquired | 2023-05-01 | Common Stock (50000) | Direct |
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Regulatory Filings
2025
Dec 16